Grace Therapeutics (GRCE) Share-based Compensation (2019 - 2026)
Grace Therapeutics' Share-based Compensation was $105,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.2% from $302,000 a year earlier and down 42.3% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Share-based Compensation (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Share-based Compensation was $601,000 through Jun 30, 2026, down 24.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $798,000, up 9.3% from FY2025.
- Share-based Compensation shows a five-year compound annual growth rate of -7.4% (FY2021 to FY2026).
- In earlier fiscal years, Share-based Compensation was $730,000 in FY2025 (-20.0%), $913,000 in FY2024 (-49.6%), $1.81 million in FY2023 (+35.5%) and $1.34 million in FY2022 (+13.9%).
- The fiscal Q1 2027 figure marks the lowest quarterly Share-based Compensation since fiscal Q1 2024.
- Compared with a year earlier, Share-based Compensation was higher in three of the last eight quarters, with an average decline of 18.9%.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q2 2023 (growth of 410.5%); the worst was fiscal Q1 2024 (a decline of 83.2%).
- Per Business Quant data, GRCE's Share-based Compensation in the three fiscal quarters before Q1 2027 was $182,000 (Q4 2026), $108,000 (Q3 2026) and $206,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 105,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 302,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Mar 31, 2024 | 229,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 280,000.00 |
| Jun 30, 2023 | 78,000.00 |
| Mar 31, 2023 | 322,000.00 |
| Dec 31, 2022 | 443.00 |
| Sep 30, 2022 | 582.00 |
| Jun 30, 2022 | 464,000.00 |
| Mar 31, 2022 | 616,000.00 |
| Dec 31, 2021 | 454,000.00 |
| Sep 30, 2021 | 114,000.00 |
API Access
Grace Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();